Russell Investments Group Ltd. grew its stake in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) by 91.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 38,679 shares of the industrial products company's stock after buying an additional 18,508 shares during the quarter. Russell Investments Group Ltd. owned 0.16% of Proto Labs worth $1,355,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of PRLB. GAMMA Investing LLC grew its stake in shares of Proto Labs by 249.4% in the first quarter. GAMMA Investing LLC now owns 926 shares of the industrial products company's stock worth $32,000 after purchasing an additional 661 shares during the last quarter. Quarry LP grew its stake in shares of Proto Labs by 175.7% in the fourth quarter. Quarry LP now owns 1,585 shares of the industrial products company's stock worth $62,000 after purchasing an additional 1,010 shares during the last quarter. CWM LLC grew its stake in shares of Proto Labs by 50.4% in the first quarter. CWM LLC now owns 1,840 shares of the industrial products company's stock worth $64,000 after purchasing an additional 617 shares during the last quarter. PNC Financial Services Group Inc. grew its stake in shares of Proto Labs by 14.1% in the first quarter. PNC Financial Services Group Inc. now owns 2,165 shares of the industrial products company's stock worth $76,000 after purchasing an additional 267 shares during the last quarter. Finally, LPL Financial LLC bought a new stake in shares of Proto Labs in the fourth quarter worth about $210,000. 84.54% of the stock is owned by institutional investors.
Insider Activity
In other Proto Labs news, CEO Suresh Krishna bought 1,725 shares of the stock in a transaction dated Monday, August 4th. The stock was purchased at an average cost of $43.51 per share, for a total transaction of $75,054.75. Following the completion of the acquisition, the chief executive officer owned 18,021 shares of the company's stock, valued at approximately $784,093.71. This trade represents a 10.59% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 1.20% of the company's stock.
Analysts Set New Price Targets
Several research firms recently issued reports on PRLB. Cantor Fitzgerald raised their target price on Proto Labs from $50.00 to $51.00 and gave the stock an "overweight" rating in a research note on Friday, August 1st. Craig Hallum raised Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 target price on the stock in a research note on Friday, August 1st. Finally, Wall Street Zen raised Proto Labs from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 2nd. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $52.50.
Read Our Latest Report on Proto Labs
Proto Labs Price Performance
PRLB traded down $1.08 on Monday, hitting $49.69. The company had a trading volume of 207,182 shares, compared to its average volume of 185,243. Proto Labs, Inc. has a 52-week low of $26.34 and a 52-week high of $51.09. The stock has a fifty day simple moving average of $43.29 and a 200-day simple moving average of $39.47. The firm has a market capitalization of $1.19 billion, a P/E ratio of 82.81 and a beta of 1.27.
Proto Labs (NYSE:PRLB - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The industrial products company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.33 by $0.08. Proto Labs had a net margin of 2.91% and a return on equity of 2.22%. The business had revenue of $135.06 million during the quarter, compared to analyst estimates of $128.05 million. During the same period last year, the business posted $0.38 earnings per share. Proto Labs's quarterly revenue was up 7.6% compared to the same quarter last year. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. Equities research analysts expect that Proto Labs, Inc. will post 0.81 earnings per share for the current fiscal year.
About Proto Labs
(
Free Report)
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
Further Reading

Before you consider Proto Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.
While Proto Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.